DEFB1 protein, human
Showing 9951 - 9975 of >10,000
Multiple Myeloma Trial in Zhengzhou, Shanghai, Wenzhou (Human BCMA targeted T Cells Injection)
Recruiting
- Multiple Myeloma
- Human BCMA targeted T Cells Injection
-
Zhengzhou, Henan, China
- +2 more
Feb 25, 2021
Cell- and Tissue-Based Therapy, Cartilage Injury, Knee Injuries Trial (Synovial Tissue and Fat Pad Stromal Vascular Fraction)
Not yet recruiting
- Cell- and Tissue-Based Therapy
- +2 more
- Synovial Tissue and Fat Pad Stromal Vascular Fraction
- (no location specified)
Nov 3, 2021
Soluble Factors and Renal Outcome in Preeclampsia
Completed
- Preeclampsia
- Renal Function
- Renal function
- proteinuria
-
Bangkok, ThailandFaculty of Medicine,Vajira Hospital
Jun 24, 2021
Combination Acthar Gel and Tacrolimus in Treatment of Steroid
Suspended
- Nephrotic Syndrome
- Acthar Gel and Tacrolimus
-
Chattanooga, TennesseeNephronet
Feb 15, 2021
HPV Vaccination on Cervical High Grade Lesions in France
Completed
- Human Papillomavirus Infection
- biological sample analysis
-
Besançon, FranceCHU Besançon
Aug 20, 2021
Malignant Melanoma, Medullary Thyroid Cancer, Glioblastoma Trial in United States (Rovalpituzumab tesirine, Dexamethasone)
Terminated
- Malignant Melanoma
- +7 more
- Rovalpituzumab tesirine
- Dexamethasone
-
Gilbert, Arizona
- +29 more
Sep 21, 2020
Diabetes, Type 2 Trial in Odense (Metformin, Caffeine, Efavirenz)
Terminated
- Diabetes Mellitus, Type 2
- Metformin
- +6 more
-
Odense, Region Of Southern Denmark, DenmarkUniversity of Southern Denmark
Jun 14, 2022
Behavior Trial in Eugene (Visual stimulus similarity, fMRI, Eye tracking)
Not yet recruiting
- Behavior
- Visual stimulus similarity
- +2 more
-
Eugene, OregonUniversity of Oregon
Oct 11, 2021
Post-polio Syndrome Trial in Worldwide (Flebogamma 5% DIF, Placebo)
Suspended
- Post-polio Syndrome
- Flebogamma 5% DIF
- Placebo
-
Saint Louis, Missouri
- +26 more
Jan 27, 2022
Chronic Granulomatous Disease Trial run by the NIAID (Sirolimus, Cyclophosphamide, Alemtuzumab)
Recruiting
- Chronic Granulomatous Disease
- Sirolimus
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 23, 2022
Sickle Cell Disease, Sickle Cell Anemia Trial run by the NHLBI (Biotin label)
Recruiting
- Sickle Cell Disease
- Sickle Cell Anemia
- Biotin label
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 11, 2022
Generate Real World Data On Tofacitinib Induction Therapy and
Recruiting
- Ulcerative Colitis
- Stool sample collection
-
Bern, Bern (de), Switzerland
- +8 more
Jan 25, 2023
Dry Eye Disease, Dry Eye, Kerato Conjunctivitis Sicca Trial in Catania (Cross-linked hyaluronic acid eye drops)
Recruiting
- Dry Eye Disease
- +3 more
- Cross-linked hyaluronic acid eye drops
-
Catania, CT, ItalyAzienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San
Apr 11, 2023
Type 1 Diabetes, Hypoglycemia, Arrythmia Trial in Cambridge, Manchester (Hybrid closed-loop system (CamAPS FX), Sensor augmented
Completed
- Type 1 Diabetes Mellitus
- +2 more
- Hybrid closed-loop system (CamAPS FX)
- Sensor augmented pump therapy
-
Cambridge, United Kingdom
- +1 more
Sep 4, 2021
Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 Trial in Worldwide
Active, not recruiting
- Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19
- Ad26.COV2.S
- Placebo
-
Vestavia Hills, Alabama
- +125 more
Jan 17, 2023
Melanoma (Skin) Trial in Madison (hu14.18-IL2 fusion protein)
Completed
- Melanoma (Skin)
- hu14.18-IL2 fusion protein
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 15, 2019
Gestational Diabetes, Pregnancy, High Risk, Overweight and Obesity Trial in Indianapolis (Intensive glycemic targets, Standard
Recruiting
- Gestational Diabetes
- +2 more
- Intensive glycemic targets
- Standard glycemic targets
-
Indianapolis, IndianaIndiana University
Mar 15, 2022
Hepatocellular Carcinoma by BCLC Stage Trial in Rennes (Tislelizumab)
Not yet recruiting
- Hepatocellular Carcinoma by BCLC Stage
-
Rennes, FranceCentre Eugene Marquis
Jan 16, 2023
Early Breast Cancer Trial in Spain (Doxorubicin, Cyclophosphamide, Taxane)
Active, not recruiting
- Early Breast Cancer
- Doxorubicin
- +5 more
-
Santiago De Compostela, A Coruña, Spain
- +27 more
Jul 11, 2022
Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)
Recruiting
- Adenocarcinoma - GEJ
- Cancer of Esophagus
- Temozolomide
- +3 more
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust
Oct 6, 2021
African Trypanosomiases, West African; Trypanosomiasis, Sleeping Sickness; West African Trial in Kinshasa, Bouaké, Conakry
Completed
- African Trypanosomiases
- +3 more
- Rapid diagnostic test (RDT)
- Serological and molecular tests on DBS
-
Kinshasa, Congo, The Democratic Republic of the
- +2 more
Feb 18, 2021
Observational Study of the Use of DBLG1 System in Real Life
Active, not recruiting
- Type1diabetes
- DBLG1 System
-
Bobigny, France
- +18 more
Mar 10, 2022
Kidney Stone Trial in Ankara (Genetic analysis)
Completed
- Kidney Stone
- Genetic analysis
-
Ankara, TurkeyOmer Gokhan Doluoglu
Mar 17, 2021